Open AccessCabozantinib Improved Hepatocellular Carcinoma Survival Beyond Sorafenib
Author(s) -
Shawn Maxwell,
Peter Goodwin
Publication year - 2018
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000549563.67811.a6
Subject(s) - sorafenib , medicine , cabozantinib , hepatocellular carcinoma , oncology , discontinuation , cancer , cirrhosis , placebo , tyrosine kinase inhibitor , pathology , alternative medicine